These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11208678)

  • 1. PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages.
    Neve BP; Corseaux D; Chinetti G; Zawadzki C; Fruchart JC; Duriez P; Staels B; Jude B
    Circulation; 2001 Jan; 103(2):207-12. PubMed ID: 11208678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARalpha activators inhibit tissue factor expression and activity in human monocytes.
    Marx N; Mackman N; Schönbeck U; Yilmaz N; Hombach V; Libby P; Plutzky J
    Circulation; 2001 Jan; 103(2):213-9. PubMed ID: 11208679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
    Paukkeri EL; Leppänen T; Sareila O; Vuolteenaho K; Kankaanranta H; Moilanen E
    Br J Pharmacol; 2007 Dec; 152(7):1081-91. PubMed ID: 17891158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages.
    Rival Y; Benéteau N; Chapuis V; Taillandier T; Lestienne F; Dupont-Passelaigue E; Patoiseau JF; Colpaert FC; Junquéro D
    DNA Cell Biol; 2004 May; 23(5):283-92. PubMed ID: 15169608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: implications for mesangial cell activation by cytokines.
    Cernuda-Morollón E; Rodríguez-Pascual F; Klatt P; Lamas S; Pérez-Sala D
    J Am Soc Nephrol; 2002 Sep; 13(9):2223-31. PubMed ID: 12191966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.
    Meissner M; Stein M; Urbich C; Reisinger K; Suske G; Staels B; Kaufmann R; Gille J
    Circ Res; 2004 Feb; 94(3):324-32. PubMed ID: 14684628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gypenoside XLIX, a naturally occurring gynosaponin, PPAR-alpha dependently inhibits LPS-induced tissue factor expression and activity in human THP-1 monocytic cells.
    Huang TH; Tran VH; Roufogalis BD; Li Y
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):30-6. PubMed ID: 17141290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element.
    Gervois P; Chopin-Delannoy S; Fadel A; Dubois G; Kosykh V; Fruchart JC; Najïb J; Laudet V; Staels B
    Mol Endocrinol; 1999 Mar; 13(3):400-9. PubMed ID: 10076997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cytokine-induced matrix metalloproteinase 9 expression by peroxisome proliferator-activated receptor alpha agonists is indirect and due to a NO-mediated reduction of mRNA stability.
    Eberhardt W; Akool el-S; Rebhan J; Frank S; Beck KF; Franzen R; Hamada FM; Pfeilschifter J
    J Biol Chem; 2002 Sep; 277(36):33518-28. PubMed ID: 12093797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor alpha reduces cholesterol esterification in macrophages.
    Chinetti G; Lestavel S; Fruchart JC; Clavey V; Staels B
    Circ Res; 2003 Feb; 92(2):212-7. PubMed ID: 12574149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Princen HM; Kooistra T
    Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism.
    Sharifpanah F; Wartenberg M; Hannig M; Piper HM; Sauer H
    Stem Cells; 2008 Jan; 26(1):64-71. PubMed ID: 17951219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.
    Hill MR; Clarke S; Rodgers K; Thornhill B; Peters JM; Gonzalez FJ; Gimble JM
    Infect Immun; 1999 Jul; 67(7):3488-93. PubMed ID: 10377130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PPARalpha agonist--fenofibrate inhibits LPS-induced tissue factor expression in THP-1 cells].
    Dong CX; Hu Y; Wang HF; Sun CY; Wang YD; He WJ; Zhang XP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1227-30. PubMed ID: 17204199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity.
    Guerre-Millo M; Gervois P; Raspé E; Madsen L; Poulain P; Derudas B; Herbert JM; Winegar DA; Willson TM; Fruchart JC; Berge RK; Staels B
    J Biol Chem; 2000 Jun; 275(22):16638-42. PubMed ID: 10828060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of endogenous genes by peroxisome proliferator activated receptor alpha ligands in a human kidney cell line and in vivo.
    Liu PC; Huber R; Stow MD; Schlingmann KL; Collier P; Liao B; Link J; Burn TC; Hollis G; Young PR; Mukherjee R
    J Steroid Biochem Mol Biol; 2003 May; 85(1):71-9. PubMed ID: 12798359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells.
    Marx N; Sukhova GK; Collins T; Libby P; Plutzky J
    Circulation; 1999 Jun; 99(24):3125-31. PubMed ID: 10377075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low thrombogenicity of calcified atherosclerotic plaques is associated with bone morphogenetic protein-2-dependent inhibition of tissue factor expression.
    Egorina EM; Sovershaev MA; Bogdanov VY; Sovershaev TA; Fallon JT; Seredkina N; Østerud B; Hansen JB
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):642-50. PubMed ID: 21897206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta5 desaturase mRNA levels are increased by simvastatin via SREBP-1 at early stages, not via PPARalpha, in THP-1 cells.
    Risé P; Ghezzi S; Carissimi R; Mastromauro F; Petroni A; Galli C
    Eur J Pharmacol; 2007 Oct; 571(2-3):97-105. PubMed ID: 17655842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.
    Goya K; Sumitani S; Xu X; Kitamura T; Yamamoto H; Kurebayashi S; Saito H; Kouhara H; Kasayama S; Kawase I
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):658-63. PubMed ID: 14751809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.